|
1
|
Farges O and Fuks D: Clinical presentation
and management of intrahepatic cholangiocarcinoma. Gastroenterol
Clin Biol. 34:191–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luh F, Kuei A, Fann P, Chu P and Yen Y:
Intrahepatic cholangiocarcinoma and hepatitis: Case study and
literature review. Anticancer Res. 29:3239–3243. 2009.PubMed/NCBI
|
|
3
|
Aishima S, Nishihara Y, Iguchi T, Taguchi
K, Taketomi A, Maehara Y and Tsuneyoshi M: Lymphatic spread is
related to VEGF-C expression and D2-40-positive myofibroblasts in
intrahepatic cholangiocarcinoma. Mod Pathol. 21:256–264. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park BK, Paik YH, Park JY, Park KH, Bang
S, Park SW, Chung JB, Park YN and Song SY: The clinicopathologic
significance of the expression of vascular endothelial growth
factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol.
29:138–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen L, Yan HX, Yang W, Hu L, Yu LX, Liu
Q, Li L, Huang DD, Ding J, Shen F, et al: The role of microRNA
expression pattern in human intrahepatic cholangiocarcinoma. J
Hepatol. 50:358–369. 2009. View Article : Google Scholar
|
|
9
|
Zeng B, Li Z, Chen R, Guo N, Zhou J, Zhou
Q, Lin Q, Cheng D, Liao Q, Zheng L and Gong Y: Epigenetic
regulation of miR-124 by hepatitis C virus core protein promotes
migration and invasion of intrahepatic cholangiocarcinoma cells by
targeting SMYD3. FEBS Lett. 586:3271–3278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oishi N, Kumar MR, Roessler S, Ji J,
Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, et al:
Transcriptomic profiling reveals hepatic stem-like gene signatures
and interplay of miR-200c and epithelial-mesenchymal transition in
intrahepatic cholangiocarcinoma. Hepatology. 56:1792–1803. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gui T and Shen K: miRNA-101: A potential
target for tumor therapy. Cancer Epidemiol. 36:537–540. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Han C, Zhu H, Song K and Wu T:
miR-101 inhibits cholangiocarcinoma angiogenesis through targeting
vascular endothelial growth factor (VEGF). Am J Pathol.
182:1629–1639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lei Q, Shen F, Wu J, Zhang W, Wang J and
Zhang L: MiR-101, downregulated in retinoblastoma, functions as a
tumor suppressor in human retinoblastoma cells by targeting EZH2.
Oncol Rep. 32:261–269. 2014.PubMed/NCBI
|
|
14
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui J, Eldredge JB, Xu Y and Puett D:
MicroRNA expression and regulation in human ovarian carcinoma cells
by luteinizing hormone. PLoS One. 6:e217302011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hiroki E, Akahira J, Suzuki F, Nagase S,
Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA
expression levels correlate with clinicopathological features and
prognoses in endometrial serous adenocarcinomas. Cancer Sci.
101:241–249. 2010. View Article : Google Scholar
|
|
18
|
Lin C, Huang F, Zhang YJ, Tuokan T and
Kuerban G: Roles of MiR-101 and its target gene Cox-2 in early
diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer
Prev. 15:45–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pang Y, Young CY and Yuan H: MicroRNAs and
prostate cancer. Acta Biochim Biophys Sin (Shanghai). 42:363–369.
2010. View Article : Google Scholar
|
|
20
|
Yan F, Shen N, Pang J, Xie D, Deng B,
Molina JR, Yang P and Liu S: Restoration of miR-101 suppresses lung
tumorigenesis through inhibition of DNMT3a-dependent DNA
methylation. Cell Death Dis. 5:e14132014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Li L, Guo R, Li X, Lu Y, Guan X,
Gitau SC, Wang L, Xu C, Yang B and Shan H: miR-101 promotes breast
cancer cell apoptosis by targeting Janus kinase 2. Cell Physiol
Biochem. 34:413–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He XP, Shao Y, Li XL, Xu W, Chen GS, Sun
HH, Xu HC, Xu X, Tang D, Zheng XF, et al: Downregulation of miR-101
in gastric cancer correlates with cyclooxygenase-2 overexpression
and tumor growth. FEBS J. 279:4201–4212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang K, Zhang Y, Ren K, Zhao G, Yan K and
Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by
downregulation of EZH2 expression. Oncol Rep. 32:2143–2149.
2014.PubMed/NCBI
|
|
24
|
Wang C, Lu S, Jiang J, Jia X, Dong X and
Bu P: Hsa-microRNA-101 suppresses migration and invasion by
targeting Rac1 in thyroid cancer cells. Oncol Lett. 8:1815–1821.
2014.PubMed/NCBI
|
|
25
|
Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G,
Fu S, Zhang Y, Feng K and Feng Y: microRNA-128 plays a critical
role in human non-small cell lung cancer tumourigenesis,
angiogenesis and lymphangiogenesis by directly targeting vascular
endothelial growth factor-C. Eur J Cancer. 50:2336–2350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Olofsson B, Jeltsch M, Eriksson U and
Alitalo K: Current biology of VEGF-B and VEGF-C. Curr Opin
Biotechnol. 10:528–535. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su JL, Yen CJ, Chen PS, Chuang SE, Hong
CC, Kuo IH, Chen HY, Hung MC and Kuo ML: The role of the
VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer. 96:541–545.
2007. View Article : Google Scholar
|
|
28
|
Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y,
Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, et al: High expression of
Dickkopf-related protein 1 is related to lymphatic metastasis and
indicates poor prognosis in intrahepatic cholangiocarcinoma
patients after surgery. Cancer. 119:993–1003. 2013. View Article : Google Scholar
|
